logo
Select company
Select metric
$ 1.18MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
35
Sector
62
Industry
62
History
100
$ 1.61Close
$ 1.27 - $ 5.1 52-Week Range
Ticker Information

Ticker

MXCT

Company Name

MAXCYTE INC

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

MAXCYTE INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MXCT - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 1.18M
3/31/2025$ 1.74M
12/31/2024$ 2.06M
9/30/2024$ 2.14M
6/30/2024$ 1.95M
3/31/2024$ 1.39M
12/31/2023$ 2.14M
9/30/2023$ 2.88M
6/30/2023$ 3.28M
3/31/2023$ 3.45M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MAXCYTE INC's latest trailing twelve months (TTM) CF - Equity stands at $ 28.97M.
  • Over the past 5 years, MAXCYTE INC's average CF - Equity has been $ 41.9M.
  • The median CF - Equity for MAXCYTE INC during this period was $ 2.87M
  • MAXCYTE INC reached its highest CF - Equity over the past 5 years at $ 239.71M.
  • The lowest CF - Equity recorded by MAXCYTE INC in the same timeframe $ 1.18M

MAXCYTE INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
TLSI : TRISALUS LIFE SCIENCES INC $ 29.86MCLPT : CLEARPOINT NEURO INC $ 3.74MSNWV : SANUWAVE HEALTH INC $ 10.55MRPID : RAPID MICRO BIOSYSTEMS INC $ 583KCVRX : CVRX INC $ 44.2MTKNO : ALPHA TEKNOVA INC $ 15.3MEDIT : EDITAS MEDICINE INC $ 9.12MMASS : 908 DEVICES INC $ 1.05MFENC : FENNEC PHARMACEUTICALS INC $ 0CTSO : CYTOSORBENTS CORP $ 6.96M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

MXCT - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ 1.18M

Minimum

Jun 30, 2025

$ 239.71M

Maximum

Dec 31, 2021

$ 41.9M

Average

$ 2.87M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 124.49K with a standard deviation of $ 17.66M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.9K
min$ -60.59M
max$ 60.64M
average$ 124.49K
median$ 0
std$ 17.66M